PubMed:27783941 / 961-1134
Annnotations
PubMed_ArguminSci
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T8 | 0-173 | DRI_Outcome | denotes | The zebrafish CNS-PNET model was used to show that MEK inhibitors selectively eliminate Olig2(+)/Sox10(+) CNS-PNET tumors in vivo without impacting normal brain development. |
Goldhamster2_Cellosaurus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T13 | 18-22 | CVCL_4431|Cancer_cell_line|Homo sapiens | denotes | PNET |
| T14 | 110-114 | CVCL_4431|Cancer_cell_line|Homo sapiens | denotes | PNET |
GoldHamster
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T108 | 4-13 | 7955 | denotes | zebrafish |
| T109 | 4-13 | D015027 | denotes | zebrafish |
| T110 | 14-17 | UBERON:0001017 | denotes | CNS |
| T113 | 18-22 | CVCL_4431 | denotes | PNET |
| T111 | 18-22 | D018242 | denotes | PNET |
| T112 | 18-22 | D018242 | denotes | PNET |
| T115 | 51-65 | CHEBI:88286 | denotes | MEK inhibitors |
| T116 | 51-65 | CHEBI:79091 | denotes | MEK inhibitors |
| T118 | 88-93 | PR:Q9EQW6 | denotes | Olig2 |
| T119 | 88-93 | PR:000011632 | denotes | Olig2 |
| T120 | 88-93 | PR:Q90XB3 | denotes | Olig2 |
| T121 | 88-93 | PR:Q13516 | denotes | Olig2 |
| T133 | 97-102 | PR:Q04888 | denotes | Sox10 |
| T134 | 97-102 | PR:P56693 | denotes | Sox10 |
| T135 | 97-102 | PR:O55170 | denotes | Sox10 |
| T136 | 97-102 | PR:Q9W757 | denotes | Sox10 |
| T137 | 97-102 | PR:000015418 | denotes | Sox10 |
| T138 | 106-109 | UBERON:0001017 | denotes | CNS |
| T141 | 110-114 | CVCL_4431 | denotes | PNET |
| T139 | 110-114 | D018242 | denotes | PNET |
| T140 | 110-114 | D018242 | denotes | PNET |
| T142 | 115-121 | D009369 | denotes | tumors |
| T143 | 115-121 | D009369 | denotes | tumors |
| T144 | 155-160 | UBERON:6110636 | denotes | brain |
| T145 | 155-160 | UBERON:0000955 | denotes | brain |
| T146 | 155-172 | GO:0007420 | denotes | brain development |